A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Consumers want connected medical devices, but demand for digital experts could put further strains on the talent pool for medtech

by Pedro Arboleda, Managing Director, Deloitte Monitor

This week, my colleagues and I are attending AdvaMed’s annual MedTech Conference. Participants will hear about the latest innovations, such as new digital products that incorporate the latest advances in wireless technology and increasingly powerful computing capabilities for generating clinical and economic insights. But I worry the industry might overlook another important change that is occurring in parallel—the ability to attract the specific digital talent needed to deliver on the promise of connected medical devices.

Read more

Real-world evidence is helping some biopharma companies develop therapies for peanut allergies

by Steve Davis, Deloitte Center for Health Solutions

On July 11, my 10-year-old son ate a peanut. This is hardly a noteworthy event for most kids, but it could be life-changing for him. Unlike the other times Ian has eaten something that contained peanut, this time we weren’t fumbling for an epinephrine auto-injector while speeding to the emergency room. Instead, we sat calmly in our allergist’s office and watched cartoons.

Read more

Digitizing life sciences R&D, one step at a time

by Dawn Anderson, Managing director, Deloitte Consulting LLP

For a life sciences industry whose Research & Development (R&D) processes are often held over from the 1990s—and whose returns on those investments are falling sharply—new digital technologies might feel as if they can’t arrive fast enough.

Almost everywhere you turn, there seems to be an opportunity as outlined in Deloitte’s recent report,

Read more

Digital R&D: Four ways to maximize patient engagement in clinical trials

by Dawn Anderson, Managing director, Deloitte Consulting LLP

The Deloitte Center for Health Solutions recently interviewed 43 biopharmaceutical industry stakeholders to explore where the industry sees value and opportunities for using digital technologies in the clinical development process; understand reasons behind the relatively slow pace of digital adoption; and uncover strategies to overcome barriers and accelerate the use of digital in clinical trials.

Read more

Five barriers that could keep biosimilar manufacturers from cracking the US market

by James Forsyth, Director, Deloitte MCS Limited, and Cameron McClearn, Principal, Deloitte Consulting LLP

The biosimilars market in the US has lagged well behind the European market for more than a decade.1 While a recent push from the White House could help expand the use of biosimilars in the US, manufacturers could still face some significant challenges there.

In April, the administration released its “blueprint” for lowering drug prices and reducing out-of-pocket costs for US consumers.

Read more

The next generation of scientists are digital natives ready to problem solve and innovate

by Juergen A. Klenk, Ph.D, Principal, Deloitte Consulting LLP

This week Deloitte and the National Institutes of Health’s National Library of Medicine (NLM) will recognize two student-led research teams from San Diego State University (SDSU) and Kingsborough Community College of The City University of New York (KCC CUNY) for their groundbreaking research in the Microbial Metagenomics Discovery Challenge.

The undergraduate students’ work was impressive by any standard.

Read more